{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:10:45Z","timestamp":1781313045740,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pieces of evidence strongly indicate that providing high-quality family planning services is accompanied by an increase in contraceptive uptake and a decrease in contraception discontinuation. Contraceptive, especially Implanon discontinuation is a global issue that could be linked to a summary outcome indicator of poor family planning service quality. Although Implanon is becoming more popular among Ethiopian contraceptive users, little is known regarding the survival and predictors of discontinuation. The study aimed at exploring the survival and predictors of Implanon discontinuation among women enrolled in family planning units of Public hospitals in southern Ethiopia, 2021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A hospital-based retrospective cohort study was conducted among Implanon users who enrolled in family planning units of Public Hospitals. Five years of medical records, from January 1, 2016, to December 30, 2020, were reviewed. A total of 502 women were selected by using a random sampling technique. A standardized abstraction tool was used to collect data from medical records and registration books. The data were entered into Epidata Version 3.1 and then exported to STATA 14 for analysis. The median was calculated in the case of survival time. Across covariates, the Kaplan Meier survival curve was used to estimate time to Implanon discontinuation. To identify statistically significant predictors of Implanon discontinuation, a multivariable Cox proportional hazard model was fitted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The incidence rate of Implanon discontinuation was 1.87(95% CI\u2009=\u20091.63, 2.15) per 100 person-months of observation. The overall estimated survival probability at the end of 24 and 36\u2009months was 67.4% (95%CI, 62.5, 71.8) and 25.9% (95%CI, 18.4, 34.1) months respectively. Residence [AHR\u2009=\u20091.50; 95%CI: 1.09, 2.08], parity [AHR\u2009=\u20092.02; 95%CI: 1.65, 3.67], pre-insertion counselling [AHR\u2009=\u20092.41; 95%CI: 1.72, 3.70], experiencing heavy vaginal bleeding [AHR\u2009=\u20093.91; 95%CI: 2.67, 5.32], post-insertion follow up [AHR\u2009=\u20093.15; 95%CI:2.11, 4.75] were identified as a significant predictors of Implanon discontinuation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The risk Implanon of discontinuation was high, especially at 24 and 36\u2009months. In family planning service delivery points, health care providers should pay special attention to clients who live in rural areas and do not have children. In addition, health care providers should provide pre-insertion counseling and post-insertion follow-up that focus on potential side effects. Finally, family planning units need to engage in early side effect management and reassurance to mitigate discontinuation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13690-022-00859-6","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T05:02:31Z","timestamp":1648011751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival time to Implanon discontinuation and its predictors among a cohort of Implanon users who enrolled in public hospitals of southern Ethiopia, 2021: a retrospective cohort study"],"prefix":"10.1186","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-4294","authenticated-orcid":false,"given":"Aklilu","family":"Habte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merertu","family":"Wondimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Abdulkadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"859_CR1","volume-title":"Social Affairs, Trends in contraceptive use worldwide 2015","author":"United Nations, D.o.E. and P.D","year":"2015","unstructured":"United Nations, D.o.E. and P.D. Social Affairs, Trends in contraceptive use worldwide 2015. ST\/ESA\/SER. A\/349, 2015."},{"key":"859_CR2","volume-title":"Family planning programs for the 21st century: rationale and design","author":"J Bongaarts","year":"2012","unstructured":"Bongaarts J, et al. Family planning programs for the 21st century: rationale and design. 2012."},{"issue":"4","key":"859_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","volume":"41","author":"S Singh","year":"2010","unstructured":"Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plan. 2010;41(4):241\u201350.","journal-title":"Stud Fam Plan"},{"issue":"4","key":"859_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1728-4465.2015.00038.x","volume":"46","author":"JN Mumah","year":"2015","unstructured":"Mumah JN, et al. Contraceptive adoption, discontinuation, and switching among postpartum women in Nairobi's urban slums. Stud Fam Plan. 2015;46(4):369\u201386.","journal-title":"Stud Fam Plan"},{"issue":"1","key":"859_CR5","first-page":"142","volume":"32","author":"FA Huda","year":"2014","unstructured":"Huda FA, Chowdhuri S, Sirajuddin MFR. Importance of appropriate counselling in reducing early discontinuation of implant in a northern district of Bangladesh. J Health Popul Nutr. 2014;32(1):142.","journal-title":"J Health Popul Nutr"},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.contraception.2009.06.009","volume":"81","author":"M Ali","year":"2010","unstructured":"Ali M, Cleland J. Oral contraceptive discontinuation and its aftermath in 19 developing countries. Contraception. 2010;81:22\u20139.","journal-title":"Contraception"},{"key":"859_CR7","doi-asserted-by":"crossref","unstructured":"Feeser K, et al. Measures of family planning service quality associated with contraceptive discontinuation: an analysis of measurement, Learning & Evaluation (MLE) project data from urban Kenya. Gates open research. 2019;3.","DOI":"10.12688\/gatesopenres.12974.1"},{"key":"859_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/OAJC.S76070","volume":"6","author":"RA Mahumud","year":"2015","unstructured":"Mahumud RA, et al. Prevalence and associated factors of contraceptive discontinuation and switching among Bangladeshi married women of reproductive age. Open Access J Contracept. 2015;6:13.","journal-title":"Open Access J Contracept"},{"key":"859_CR9","first-page":"17","volume":"54","author":"S Staveteig","year":"2015","unstructured":"Staveteig S, Mallick L, Winter R. Uptake and discontinuation of long-acting reversible contraceptives (Larcs) in lowincome countries. Dhs Analytical Studies. 2015;54:17\u201377.","journal-title":"Dhs Analytical Studies"},{"key":"859_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2307\/3181061","volume":"29","author":"S RamaRao","year":"2013","unstructured":"RamaRao S, Lacuesta M, Costello M, Pangolibay B, Jones H. The link between quality of care and contraceptive use. Int Fam Plan Perspect. 2013;29:76\u201383.","journal-title":"Int Fam Plan Perspect"},{"key":"859_CR11","unstructured":"FPA. Your guide to long-acting reversible contraception (LARC). Public Health Engl. 2017; (september):1\u20132. https:\/\/www.nwlondonsexualhealth.nhs.uk\/resources_ealing\/long-acting-reversible-contraception-your-guide.pdf."},{"issue":"1","key":"859_CR12","first-page":"46","volume":"26","author":"AO Roberts","year":"2015","unstructured":"Roberts AO, et al. Profile of Implanon\u00ae acceptors and pattern of side effects. J Reprod Contracept. 2015;26(1):46\u201352.","journal-title":"J Reprod Contracept"},{"issue":"4","key":"859_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0015-0282(98)00015-6","volume":"69","author":"L Makarainen","year":"2009","unstructured":"Makarainen L, van Beek A, Tuomivaara L, Asplund B, Coelingh BH. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril. 2009;69(4):714\u201321.","journal-title":"Fertil Steril"},{"key":"859_CR14","doi-asserted-by":"crossref","unstructured":"McDonald-Mosley R, Burke AE. Contraceptive implants. in Seminars in reproductive medicine: \u00a9 Thieme Medical Publishers; 2010.","DOI":"10.1055\/s-0030-1248135"},{"issue":"4","key":"859_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.contraception.2011.02.007","volume":"84","author":"D Hubacher","year":"2011","unstructured":"Hubacher D, et al. Factors associated with uptake of subdermal contraceptive implants in a young Kenyan population. Contraception. 2011;84(4):413\u20137.","journal-title":"Contraception"},{"key":"859_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/humrep\/14.4.976","volume":"14","author":"HB Croxatto","year":"2012","unstructured":"Croxatto HB, Urbancsek J, Massai R, Coelingh BH, van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group Hum Reprod. 2012;14:976\u201381.","journal-title":"Implanon Study Group Hum Reprod"},{"key":"859_CR17","doi-asserted-by":"crossref","unstructured":"Melkamu Asaye M, Syoum Nigussie T, Mequannt Ambaw W. Early Implanon discontinuation and associated factors among Implanon user women in Debre Tabor town, public health facilities, Northwest Ethiopia, 2016. Int J Reproduct Med. 2018:2018.","DOI":"10.1155\/2018\/3597487"},{"key":"859_CR18","volume-title":"Levels, Trends and Reasons for Contraceptive Discontinuation. DHS Analytical Studies No. 20","author":"S Bradley","year":"2009","unstructured":"Bradley S, Schwandt HM, Khan S. Levels, Trends and Reasons for Contraceptive Discontinuation. DHS Analytical Studies No. 20. Calverton: ICF Macro; 2009. https:\/\/www.dhsprogram.com\/publications\/publication-as20-analytical-studies.cfm."},{"issue":"10","key":"859_CR19","first-page":"701","volume":"45","author":"S Chirina","year":"2013","unstructured":"Chirina S, et al. Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med. 2013;45(10):701\u20137.","journal-title":"Fam Med"},{"key":"859_CR20","first-page":"63","volume":"66","author":"KK Singh","year":"2012","unstructured":"Singh KK, Roy TK, Singh BP. Contraceptive discontinuation and switching patterns in Bangladesh. Genus. 2012;66:63\u201388.","journal-title":"Genus"},{"key":"859_CR21","unstructured":"MEHZABIN S1, KUTUBI A2, ELAHI MM3, BAR D4, MANNI UJA5, ISLAM M6, factors responsible for premature discontinuation of long acting reversible contraceptives a study conducted in model family planning clinic of Dhaka medical college hospital over a period of one year."},{"issue":"3","key":"859_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0010-7824(95)00012-Y","volume":"51","author":"S Datey","year":"1995","unstructured":"Datey S, Gaur LN, Saxena BN. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)\u2014an Indian experience: an ICMR task force study. Contraception. 1995;51(3):155\u201365.","journal-title":"Contraception"},{"key":"859_CR23","volume-title":"Uptake and discontinuation of long-acting reversible contraceptives (LARCS) in low-income countries","author":"S Staveteig","year":"2015","unstructured":"Staveteig S, Mallick L, Winter R. Uptake and discontinuation of long-acting reversible contraceptives (LARCS) in low-income countries; 2015."},{"issue":"4","key":"859_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmjsrh-2017-101860","volume":"44","author":"MM Aziz","year":"2018","unstructured":"Aziz MM, El-Gazzar AF, Elgibaly O. Factors associated with first-year discontinuation of Implanon in upper Egypt: clients\u2019 and providers\u2019 perspectives. BMJ sexual & reproductive health. 2018;44(4):260\u20136.","journal-title":"BMJ sexual & reproductive health"},{"key":"859_CR25","first-page":"448","volume":"20","author":"HU Ezegwui","year":"2014","unstructured":"Ezegwui HU, Ikeako LC, Ishiekwene CI, et al. The discontinuation rate and reasons for discontinuation of Implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu. Nigeria Niger J Med. 2014;20:448\u201350.","journal-title":"Nigeria Niger J Med"},{"issue":"11","key":"859_CR26","doi-asserted-by":"publisher","first-page":"e0241605","DOI":"10.1371\/journal.pone.0241605","volume":"15","author":"S Ontiri","year":"2020","unstructured":"Ontiri S, et al. Patterns and determinants of modern contraceptive discontinuation among women of reproductive age: analysis of Kenya demographic health surveys, 2003\u20132014. PLoS One. 2020;15(11):e0241605.","journal-title":"PLoS One"},{"key":"859_CR27","unstructured":"Steyn P, (Sa) F, Phil M, Kluge DJ, Med M. Contraceptives: a guide to product selection. 2016.\u00a0\u00a0https:\/\/worldwidescience.org\/topicpages\/l\/longacting+reversible+contraception.html. Accessed 20 Nov 2021."},{"key":"859_CR28","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.ijgo.2013.07.003","volume":"123","author":"M Asnake","year":"2013","unstructured":"Asnake M, Henry EG, Tilahun Y, Oliveras E. Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users. Int J Gynecol Obstet. 2013;123:e29\u201332.","journal-title":"Int J Gynecol Obstet"},{"key":"859_CR29","volume-title":"Including long-acting contraceptive services at selected health centers and their health posts in four regions of Ethiopia: a situational analysis","author":"Community-based family planning","year":"2015","unstructured":"Community-based family planning. Including long-acting contraceptive services at selected health centers and their health posts in four regions of Ethiopia: a situational analysis. Ethiopia: Addis Ababa; 2015."},{"key":"859_CR30","volume-title":"Ethiopia demographic and health survey 2016","author":"ICF.","year":"2016","unstructured":"ICF. Central statistical agency (CSA) [Ethiopia]. In:  Ethiopia demographic and health survey 2016. Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF; 2016."},{"issue":"3","key":"859_CR31","first-page":"544","volume":"6","author":"K Birhane","year":"2015","unstructured":"Birhane K, Hagos S, Fantahun M. Early discontinuation of implanon and its associated factors among women who ever used implanon in Ofla District, Tigray, northern Ethiopia. Int J Pharm Sci Res. 2015;6(3):544\u201351.","journal-title":"Int J Pharm Sci Res"},{"key":"859_CR32","first-page":"8","volume":"2","author":"M Siyoum","year":"2017","unstructured":"Siyoum M, Mulaw Z, Abuhay M, Kebebe H. Implanon discontinuation rate and associated factors among women who ever used Implanon in the last three years in Debre Markos town, Northwest Ethiopia, 2016, cross sectional study. ARC J Public Health Commun Med. 2017;2:8\u201316.","journal-title":"ARC J Public Health Commun Med"},{"issue":"2","key":"859_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1728-4465.2002.00127.x","volume":"33","author":"A Blanc","year":"2002","unstructured":"Blanc A, Curtis SL, Croft TN. Monitoring contraceptive continuation: links to fertility outcomes and quality of care. Stud Fam Plan. 2002;33(2):127\u201340.","journal-title":"Stud Fam Plan"},{"issue":"5","key":"859_CR34","doi-asserted-by":"publisher","first-page":"e0232582","DOI":"10.1371\/journal.pone.0232582","volume":"15","author":"P Akilimali","year":"2020","unstructured":"Akilimali P, KP K. Incidence and determinants of Implanon discontinuation: findings from a prospective cohort study in three health zones in Kinshasa, DRC. PLoS One. 2020;15(5):e0232582.","journal-title":"PLoS One"},{"key":"859_CR35","unstructured":"Guraghe zone statistical abstract, SNNPR, Wolkite, 2018\u20132019, 2020."},{"issue":"2","key":"859_CR36","first-page":"48","volume":"24","author":"E Ohazurike","year":"2020","unstructured":"Ohazurike E, et al. Predictors of discontinuation of subdermal Levonorgestrel implants (Jadelle) at the Lagos University teaching hospital, Lagos, Nigeria: an analytic cohort study. Afr J Reprod Health. 2020;24(2):48\u201363.","journal-title":"Afr J Reprod Health"},{"issue":"1","key":"859_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-90373-6","volume":"11","author":"U Jaisamrarn","year":"2021","unstructured":"Jaisamrarn U, Santipap M, Santibenchakul S. Discontinuation rates of different contraceptive methods in Thai women up to 1-year after method initiation. Sci Rep. 2021;11(1):1\u20137.","journal-title":"Sci Rep"},{"issue":"1","key":"859_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-018-0529-9","volume":"18","author":"J Barden-O\u2019Fallon","year":"2018","unstructured":"Barden-O\u2019Fallon J, et al. Women\u2019s contraceptive discontinuation and switching behavior in urban Senegal, 2010\u20132015. BMC Womens Health. 2018;18(1):1\u20139.","journal-title":"BMC Womens Health"},{"issue":"1","key":"859_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-4038-6","volume":"12","author":"KG Gebrekidan","year":"2019","unstructured":"Gebrekidan KG, et al. Early Implanon discontinuation rate and its associated factors in health institutions of Mekelle City, Tigray, Ethiopia 2016\/17. BMC research notes. 2019;12(1):1\u20136.","journal-title":"BMC research notes"},{"key":"859_CR40","doi-asserted-by":"crossref","unstructured":"Bekele T., A. Gebremariam and P. Tura. Factors associated with contraceptive discontinuation in Agarfa district, bale zone, south East Ethiopia. Epidemiology: open Access, 2015. 5(1).","DOI":"10.4172\/2161-1165.1000179"},{"issue":"1","key":"859_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-018-0678-x","volume":"18","author":"A Nageso","year":"2018","unstructured":"Nageso A, Gebretsadik A. Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia. BMC women's health. 2018;18(1):1\u20139.","journal-title":"BMC women's health"},{"issue":"2","key":"859_CR42","first-page":"180","volume":"1","author":"S Kamhawi","year":"2013","unstructured":"Kamhawi S, et al. Client-centered counseling improves client satisfaction with family planning visits: evidence from Irbid. Jordan Glob Health: Scie Pract. 2013;1(2):180\u201392.","journal-title":"Jordan Glob Health: Scie Pract"},{"issue":"6","key":"859_CR43","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/01.AOG.0000435452.86108.59","volume":"122","author":"S Danielle","year":"2013","unstructured":"Danielle S, et al. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013;122(6):1214.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"859_CR44","first-page":"1","volume":"4","author":"A Burusie","year":"2015","unstructured":"Burusie A. Reasons for premature removal of Implanon among users in Arsi zone, Oromia region, Ethiopia, 2013. Reproduct Syst Sexual Disorders: Curr Res. 2015;4(1):1\u20136.","journal-title":"Reproduct Syst Sexual Disorders: Curr Res"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-022-00859-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-022-00859-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-022-00859-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T05:04:07Z","timestamp":1648011847000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-022-00859-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1186\/s13690-022-00859-6","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Institutional Review Board (IRB) of Jimma University, Institute of Health. The study\u2019s objective had been communicated to the respective hospitals via a letter of permission from the Guraghe Zone Health Department. This study was conducted per the Declaration of Helsinki. Because the study was conducted through a review of medical records and family planning service registrations, informed consent was not required; the individual subjects had not been exposed to any harm as long as anonymity was maintained. Data collectors were recruited from family planning units to maintain confidentiality, and personal identifiers were not included in the data collection format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We would like to assure you that, with full responsibility and communication, the document has been submitted. We indicated that there is no conflict of interest with other individuals or organizations that could influence or bias the content of the paper inappropriately.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}